RENB
Price
$0.71
Change
-$0.04 (-5.33%)
Updated
Jan 17 closing price
Capitalization
112.21M
TNGX
Price
$2.85
Change
+$0.07 (+2.52%)
Updated
Jan 17 closing price
Capitalization
306.14M
72 days until earnings call
Ad is loading...

RENB vs TNGX

Header iconRENB vs TNGX Comparison
Open Charts RENB vs TNGXBanner chart's image
Renovaro
Price$0.71
Change-$0.04 (-5.33%)
Volume$625.25K
Capitalization112.21M
Tango Therapeutics
Price$2.85
Change+$0.07 (+2.52%)
Volume$772.23K
Capitalization306.14M
RENB vs TNGX Comparison Chart
Loading...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RENB vs. TNGX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RENB is a Hold and TNGX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (RENB: $0.71 vs. TNGX: $2.85)
Brand notoriety: RENB and TNGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RENB: 48% vs. TNGX: 51%
Market capitalization -- RENB: $112.21M vs. TNGX: $306.14M
RENB [@Biotechnology] is valued at $112.21M. TNGX’s [@Biotechnology] market capitalization is $306.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RENB’s FA Score shows that 0 FA rating(s) are green whileTNGX’s FA Score has 1 green FA rating(s).

  • RENB’s FA Score: 0 green, 5 red.
  • TNGX’s FA Score: 1 green, 4 red.
According to our system of comparison, TNGX is a better buy in the long-term than RENB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RENB’s TA Score shows that 3 TA indicator(s) are bullish while TNGX’s TA Score has 3 bullish TA indicator(s).

  • RENB’s TA Score: 3 bullish, 5 bearish.
  • TNGX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, TNGX is a better buy in the short-term than RENB.

Price Growth

RENB (@Biotechnology) experienced а -10.78% price change this week, while TNGX (@Biotechnology) price change was -2.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

RENB is expected to report earnings on May 12, 2023.

TNGX is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TNGX($306M) has a higher market cap than RENB($112M). TNGX YTD gains are higher at: -7.767 vs. RENB (-15.380). RENB has higher annual earnings (EBITDA): -113.05M vs. TNGX (-137.2M). TNGX has more cash in the bank: 293M vs. RENB (221K). RENB has less debt than TNGX: RENB (3.82M) vs TNGX (37.6M). TNGX has higher revenues than RENB: TNGX (43.4M) vs RENB (0).
RENBTNGXRENB / TNGX
Capitalization112M306M37%
EBITDA-113.05M-137.2M82%
Gain YTD-15.380-7.767198%
P/E RatioN/AN/A-
Revenue043.4M-
Total Cash221K293M0%
Total Debt3.82M37.6M10%
FUNDAMENTALS RATINGS
RENB: Fundamental Ratings
RENB
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RENBTNGX
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bearish Trend 11 days ago
89%
Bullish Trend 11 days ago
79%
MACD
ODDS (%)
Bearish Trend 11 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
88%
Bullish Trend 11 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
86%
Bearish Trend 11 days ago
87%
Advances
ODDS (%)
Bullish Trend 13 days ago
89%
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 19 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
90%
Bearish Trend 11 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 11 days ago
84%
View a ticker or compare two or three
Ad is loading...
RENB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TNGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSUAY16.080.24
+1.52%
China Shenhua Energy Co., Ltd.
SDVKY18.820.27
+1.46%
Sandvik AB
AETUF18.350.17
+0.96%
Arc Resources Ltd.
CRLFF4.55-0.05
-1.16%
Cardinal Energy Ltd.
CGLCF0.13N/A
-3.29%
Cassiar Gold Corp.

RENB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RENB has been loosely correlated with VRCA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RENB jumps, then VRCA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RENB
1D Price
Change %
RENB100%
-5.73%
VRCA - RENB
37%
Loosely correlated
+5.80%
DTIL - RENB
36%
Loosely correlated
+5.08%
TNGX - RENB
34%
Loosely correlated
+2.52%
AAVXF - RENB
26%
Poorly correlated
N/A
QSI - RENB
26%
Poorly correlated
-11.81%
More

TNGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TNGX has been loosely correlated with AXON. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TNGX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TNGX
1D Price
Change %
TNGX100%
+2.52%
AXON - TNGX
41%
Loosely correlated
+1.37%
MDGL - TNGX
39%
Loosely correlated
+7.64%
BNTC - TNGX
36%
Loosely correlated
-6.87%
ORMP - TNGX
36%
Loosely correlated
-1.72%
VERA - TNGX
35%
Loosely correlated
+1.80%
More